“The Cost-Effectiveness of Losartan in Type 2 Diabetics With Nephropathy in Switzerland - an Analysis of the RENAAL Study”. 2004. Swiss Medical Weekly 134 (3132): 440-47. https://doi.org/10.4414/smw.2004.10492.